ALOX15 Human shRNA Plasmid Kit (Locus ID 246)
CAT#: TL314822
ALOX15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 1 publication. |
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | ALOX15 Human shRNA Plasmid Kit (Locus ID 246) |
Locus ID | 246 |
UniProt ID | P16050 |
Synonyms | 12-LOX; 15-LOX; 15-LOX-1; LOG15 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | ALOX15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 246). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001140, NM_001140.1, NM_001140.2, NM_001140.3, BC029032, BC029032.1 |
Summary | This gene encodes a member of the lipoxygenase family of proteins. The encoded enzyme acts on various polyunsaturated fatty acid substrates to generate various bioactive lipid mediators such as eicosanoids, hepoxilins, lipoxins, and other molecules. The encoded enzyme and its reaction products have been shown to regulate inflammation and immunity. Multiple pseudogenes of this gene have been identified in the human genome. [provided by RefSeq, Aug 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function
,Pistorius, K;Souza, PR;De Matteis, R;Austin-Williams, S;Primdahl, KG;Vik, A;Mazzacuva, F;Colas, RA;Marques, RM;Hansen, TV;Dalli, J;,
Cell Chem Biol
,PubMed ID 29805036
[ALOX15]
|
Documents
Product Manuals |
FAQs |
SDS |